Taxus Cardium Pharmaceuticals Group (CRXM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2007 | 12-2006 | 09-2006 | 06-2006 | 03-2006 | |
| Sales | 309 | 373 | 134 | 209 | 39 |
| Cost of Goods | 247 | 509 | 163 | 229 | 53 |
| Gross Profit | 63 | -136 | -29 | -19 | -14 |
| Operating Expenses | 6,236 | 7,525 | 5,733 | 3,994 | 2,813 |
| Operating Income | -5,926 | -7,152 | -5,599 | -3,784 | -2,774 |
| Other Income | 86 | 111 | 174 | 211 | 220 |
| Pre-tax Income | -5,840 | -7,040 | -5,426 | -3,573 | -2,554 |
| Net Income Continuous | -5,840 | -7,040 | -5,426 | -3,573 | -2,554 |
| Net Income | $-5,840 | $-7,040 | $-5,426 | $-3,573 | $-2,554 |
| EPS Basic Total Ops | -3.40 | -4.40 | -3.40 | -2.20 | -1.80 |
| EPS Basic Continuous Ops | -3.40 | -4.50 | -3.42 | -2.25 | -1.71 |
| EPS Diluted Total Ops | -3.40 | -4.40 | -3.40 | -2.20 | -1.80 |
| EPS Diluted Continuous Ops | -3.40 | -4.50 | -3.42 | -2.25 | -1.71 |
| EBITDA(a) | $-5,633 | $-6,853 | $-5,333 | $-3,516 | $-2,687 |